David Ali
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
David Ali
Acting CEO, Executive Director / Mediland Pharm
Dr Ali is a senior executive with more than 40 years experience in medical management, business development, sales and marketing for pharmaceutical, medical device and diagnostic companies in human and animal reproduction. He has held positions with prestigious organisations including CSIRO, Bayer, AstraZeneca, Novo Nordisk and Biogen. He was a member of the Association of Regulatory and Clinical Scientists where he also served an elected board term.
Lists and Charts
Total Shareholder Return as at 30/08/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1005th | Mediland Pharm | -17% | -27% |
1746 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 1036th |  | Mediland Pharm | $662k |
1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
 | NEW ROLE: CEO, Executive Director, Memphasys | 01 Aug 2024 |
| NEW ROLE: Acting CEO, Executive Director, Mediland Pharm | 01 Aug 2024 |
| NEW ROLE: Acting CEO, Executive Director, Mediland Pharm | 01 Aug 2024 |
